Article
Prospective isolation and molecular characterization of hematopoietic stem cells with durable self-renewal potential.
Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada.
Blood (impact factor:
9.9).
05/2009;
113(25):6342-50.
DOI:10.1182/blood-2008-12-192054
pp.6342-50
Source: PubMed
-
Citations (0)
- Cited In (4)
-
Article: Flow cytometry analysis of murine hematopoietic stem cells.
[show abstract] [hide abstract]
ABSTRACT: Hematopoietic stem cells (HSCs) remain the most well-characterized adult stem cell population both in terms of markers for purification and assays to assess functional potential. However, despite over 40 years of research, working with HSCs in the mouse remains challenging because of the relative abundance (or lack thereof) of these cells in the bone marrow. The frequency of HSCs in murine bone marrow is about 0.01% of total nucleated cells and ∼5,000 can be isolated from an individual mouse depending on the age, sex, and strain of mice as well as purification scheme utilized. Adding to the challenge is the continual reporting of new markers for HSC purification, which makes it difficult for the uninitiated in the field to know which purification strategies yield the highest proportion of long-term, multilineage HSCs. In this updated version of our review from 2009, we review different strategies for hematopoietic stem and progenitor cell identification and purification. We will also discuss methods for rapid flow cytometric analysis of peripheral blood cell types, and novel strategies for working with rare cell populations such as HSCs in the analysis of cell cycle status by BrdU, Ki-67, and Pyronin Y staining. The purpose of updating this review is to provide insight into some of the recent experimental and technical advances in mouse hematopoietic stem cell biology. © 2012 International Society for Advancement of Cytometry.Cytometry Part A 06/2012; · 3.73 Impact Factor -
Article: Quantifying hematopoietic stem and progenitor cell mobilization.
[show abstract] [hide abstract]
ABSTRACT: Allogeneic donor blood cells and autologous peripheral blood leukocytes (PBL), obtained following -clinical mobilization procedures, are routinely used as a major source of hematopoietic stem and progenitor cells (HSPC) for transplantation protocols. It is, therefore, essential to evaluate and to quantify the extent by which the HSPC are mobilized and enriched in the circulation in correlation with their long-term hematopoietic reconstitution capacity. In this chapter, we describe quantitative methods that measure the number of mobilized HSPC according to specific criteria, as well as their functional properties in vitro and in vivo. The described assays are useful for assessment of progenitor cell mobilization as applied to both human and murine HSPC.Methods in molecular biology (Clifton, N.J.) 01/2012; 904:15-35. -
Article: Aging-associated changes in hematopoiesis and leukemogenesis: what's the connection?
[show abstract] [hide abstract]
ABSTRACT: Aging is associated with a marked increase in a number of diseases, including many types of cancer. Due to the complex and multi-factorial nature of both aging and cancer, accurate deciphering of causative links between aging and cancer remains a major challenge. It is generally accepted that initiation and progression of cancers are driven by a process of clonal evolution. In principle, this somatic evolution should follow the same Darwinian logic as evolutionary processes in populations in nature: diverse heritable types arising as a result of mutations are subjected to selection, resulting in expansion of the fittest clones. However, prevalent paradigms focus primarily on mutational aspects in linking aging and cancer. In this review, we will argue that age-related changes in selective pressures are likely to be equally important. We will focus on aging-related changes in the hematopoietic system, where age-associated alterations are relatively well studied, and discuss the impact of these changes on the development of leukemias and other malignancies.Aging 06/2011; 3(6):643-56. · 5.13 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
2 subsets
3 new genes
adult bone marrow cells
cells capable
Comparative transcriptome analyses
constitutes extensive self-renewal capacity
dual properties
elevated expression
extensive self-renewal capacity
Hematopoietic
HSCs
lifelong self-renewal capacity
long-term repopulating cells
mouse fetal liver
phenotypically
pluripotent hematopoietic cells
repopulate primary hosts
repopulating irradiated congenic hosts
selective feature
vitro